Xiaoping Leng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoping Leng has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
Zhuo Wang
Department of Ultrasound Medicine The Second Affiliated Hospital of Harbin Medical University Harbin China
12 shared publicationsJianfeng Chen
Laboratory Animal Center, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China
9 shared publicationsShouqiang Li
Department of Ultrasound The Second Affiliated Hospital of Harbin Medical University Harbin China
8 shared publicationsChen Zhao
Department of Ultrasound Medicine The Second Affiliated Hospital of Harbin Medical University Harbin China
7 shared publicationsDandan Yu
Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China
6 shared publications- Jiawei Tian
Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
5 shared publications
Latest Publications
- 22 August 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (11) , 2431-2442
Assessing Treatment Efficacy in Alopecia Areata: A Combined High‐Frequency Ultrasound and Superb Microvascular Imaging Study
Objectives: The therapeutic goals for alopecia areata (AA) are to suppress local immune inflammation, restore hair follicle structure, and improve surrounding blood perfusion. However, current efficacy evaluations largely rely on subjective clinical observation and lack objective quantitative methods. High‐frequency ultrasound (HFUS) can clearly display the location and morphology of hair follicles. Combined with microvascular assessment techniques, it enables quantitative detection of low‐velocity blood flow and related parameters, providing an objective basis for evaluating AA treatment efficacy. Methods: Forty‐five patients with AA who received intralesional therapy underwent HFUS (measuring epidermal/dermal thickness and hair follicle length/width) and ultrasound microvascular assessment, including spectral Doppler measurement of peak systolic velocity (PSV), resistance index (RI), and power Doppler measurement of vascular index (VI) before and after treatment. Patients were divided into a responder group ( n = 37) and an ineffective group ( n = 8) based on the reduction rate of the SALT score. The Mann–Whitney U test and Wilcoxon signed‐rank test were used for comparisons between groups and within the responder group (pre‐treatment versus post‐treatment), respectively. Results: Baseline characteristics showed no statistically significant differences (all p > .05). Patients in the ineffective group exhibited poorer hair follicle morphology (shorter length, greater width, and lower length‐to‐width ratio), but higher PSV and VI compared to the responder group ( p < .05). In the responder group, treatment significantly improved hair follicle morphology, increased PSV and VI ( p < .05), but RI showed no change. Conclusions: (1) HFUS technology can observe changes in AA hair follicle structure during the diagnosis and treatment process, evaluating the effectiveness of treatment regimens in improving AA disease progression. (2) SMI combined with Doppler flow parameters can monitor changes in the perifollicular microcirculation in AA, reflecting the improvement of microcirculation during the diagnosis and treatment of AA. (3) The synergistic application of HFUS and SMI technologies can provide an objective imaging basis for the clinical evaluation of AA treatment efficacy, demonstrating promising clinical application prospects.
- 22 August 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (11) , 2431-2442
Assessing Treatment Efficacy in Alopecia Areata: A Combined High‐Frequency Ultrasound and Superb Microvascular Imaging Study
Objectives: The therapeutic goals for alopecia areata (AA) are to suppress local immune inflammation, restore hair follicle structure, and improve surrounding blood perfusion. However, current efficacy evaluations largely rely on subjective clinical observation and lack objective quantitative methods. High‐frequency ultrasound (HFUS) can clearly display the location and morphology of hair follicles. Combined with microvascular assessment techniques, it enables quantitative detection of low‐velocity blood flow and related parameters, providing an objective basis for evaluating AA treatment efficacy. Methods: Forty‐five patients with AA who received intralesional therapy underwent HFUS (measuring epidermal/dermal thickness and hair follicle length/width) and ultrasound microvascular assessment, including spectral Doppler measurement of peak systolic velocity (PSV), resistance index (RI), and power Doppler measurement of vascular index (VI) before and after treatment. Patients were divided into a responder group ( n = 37) and an ineffective group ( n = 8) based on the reduction rate of the SALT score. The Mann–Whitney U test and Wilcoxon signed‐rank test were used for comparisons between groups and within the responder group (pre‐treatment versus post‐treatment), respectively. Results: Baseline characteristics showed no statistically significant differences (all p > .05). Patients in the ineffective group exhibited poorer hair follicle morphology (shorter length, greater width, and lower length‐to‐width ratio), but higher PSV and VI compared to the responder group ( p < .05). In the responder group, treatment significantly improved hair follicle morphology, increased PSV and VI ( p < .05), but RI showed no change. Conclusions: (1) HFUS technology can observe changes in AA hair follicle structure during the diagnosis and treatment process, evaluating the effectiveness of treatment regimens in improving AA disease progression. (2) SMI combined with Doppler flow parameters can monitor changes in the perifollicular microcirculation in AA, reflecting the improvement of microcirculation during the diagnosis and treatment of AA. (3) The synergistic application of HFUS and SMI technologies can provide an objective imaging basis for the clinical evaluation of AA treatment efficacy, demonstrating promising clinical application prospects.
- 17 July 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (12) , 2725-2738
Prediction of Central Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Multi‐Ultrasound Radiomics of Intratumoral and Peritumoral Regions
Objective: The aim of this study was to integrate multimodal intratumoral and peritumoral ultrasound radiomic features with clinical data to construct a predictive model for central lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC) and to explore its clinical utility. Methods: A total of 470 PTC patients who underwent 2‐dimensional (2D) ultrasound, color Doppler flow imaging (CDFI), and strain elastography (SE) were enrolled between June 2021 and September 2023. Patients were randomly divided into a training group (n = 329) and a validation group (n = 141) in a 7:3 ratio. Imaging features were extracted from multimodal intratumoral and peritumoral ultrasound images, followed by feature selection. A multimodal intratumoral and peritumoral ultrasound radiomics model was constructed using machine learning algorithms. Univariate and multivariate logistic regression analyses identified independent clinical predictors, which were used to build a clinical model. The ultrasound radiomics model was then integrated with the clinical model to form a combined model (the RadClip model). Results: The multimodal intratumoral and peritumoral radiomics model achieved AUCs of 0.936 and 0.843 in the training and validation groups. Multivariate analysis identified male, high elasticity score, irregular margins, hyperechoic areas, and the presence of suspicious lymph nodes as independent predictors of CLNM ( P < .05). The clinical model achieved AUCs of 0.750 and 0.735 in the training and validation groups, respectively. The RadClip model demonstrated significantly superior predictive performance compared to both the clinical and radiomics models, achieving AUCs of 0.948 and 0.867 in the training and validation groups, respectively (Delong, P < .05). Conclusion: The RadClip model demonstrates excellent predictive efficacy for preoperative detection of CLNM in PTC.
- 17 July 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (12) , 2725-2738
Prediction of Central Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Multi‐Ultrasound Radiomics of Intratumoral and Peritumoral Regions
Objective: The aim of this study was to integrate multimodal intratumoral and peritumoral ultrasound radiomic features with clinical data to construct a predictive model for central lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC) and to explore its clinical utility. Methods: A total of 470 PTC patients who underwent 2‐dimensional (2D) ultrasound, color Doppler flow imaging (CDFI), and strain elastography (SE) were enrolled between June 2021 and September 2023. Patients were randomly divided into a training group (n = 329) and a validation group (n = 141) in a 7:3 ratio. Imaging features were extracted from multimodal intratumoral and peritumoral ultrasound images, followed by feature selection. A multimodal intratumoral and peritumoral ultrasound radiomics model was constructed using machine learning algorithms. Univariate and multivariate logistic regression analyses identified independent clinical predictors, which were used to build a clinical model. The ultrasound radiomics model was then integrated with the clinical model to form a combined model (the RadClip model). Results: The multimodal intratumoral and peritumoral radiomics model achieved AUCs of 0.936 and 0.843 in the training and validation groups. Multivariate analysis identified male, high elasticity score, irregular margins, hyperechoic areas, and the presence of suspicious lymph nodes as independent predictors of CLNM ( P < .05). The clinical model achieved AUCs of 0.750 and 0.735 in the training and validation groups, respectively. The RadClip model demonstrated significantly superior predictive performance compared to both the clinical and radiomics models, achieving AUCs of 0.948 and 0.867 in the training and validation groups, respectively (Delong, P < .05). Conclusion: The RadClip model demonstrates excellent predictive efficacy for preoperative detection of CLNM in PTC.
- Open Access
- 6 July 2026
- Published by Elsevier in Journal of Advanced Research
MDH1 K298 succinylation stabilizes redox homeostasis to protect against cardiac ferroptosis in ischemia–reperfusion injury
- 6 July 2026
- Published by Elsevier in Journal of Advanced Research
Open AccessMDH1 K298 succinylation stabilizes redox homeostasis to protect against cardiac ferroptosis in ischemia–reperfusion injury
- Open Access
- 14 June 2026
- Published by Elsevier in Materials Today Bio
- Vol. 39, 103349
Ultrasound-driven microbubble motors for targeted myocardial ischemia-reperfusion injury treatment
- 14 June 2026
- Published by Elsevier in Materials Today Bio
- Vol. 39, 103349
Open AccessUltrasound-driven microbubble motors for targeted myocardial ischemia-reperfusion injury treatment
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 13, 1-17
Contrast-Enhanced CT Shell Features and Deep Learning for Predicting Early Transarterial Chemoembolization Refractoriness in Hepatocellular Carcinoma
Purpose: The aim of this study was to develop and validate a predictive model for early refractoriness to transarterial chemoembolization (TACE)—termed early TACE refractoriness (ETR)—in patients with hepatocellular carcinoma (HCC). The model integrates contrast-enhanced CT (CECT) shell features (annular features at the tumor-liver parenchyma interface) with the Vision-Mamba (Vim) architecture, known for its efficiency in handling high-resolution medical images. Patients and Methods: This study was a two-center and retrospective study. Patients from center 1 were divided into the training set (n=254) and validation set (n=108), while patients from center 2 were used as the testing set (n=75). A joint model was constructed to predict ETR, and four Vim models without clinical features and 14 machine learning models based on clinical features were also developed for comparison. Model performance was evaluated by the accuracy, area under the curve (AUC), calibration curve, sensitivity, specificity, decision curve analysis (DCA) and Delong test. SHapley Additive exPlanations(SHAP) analysis were used to explain the predictions. Results: The combined model based on the Vim framework performs better than others. The AUC of the combined model in the training set, validation set and test set were 0.959, 0.956 and 0.942, respectively. The calibration curve and DCA verified the practicality of the combined model in clinical practice. SHAP provides a visual interpretation of the model. Conclusion: The Vim-based model integrating CECT and shell features shows promise for ETR prediction, offering a preliminary stratification tool. However, it remains a promising step rather than a definitive solution, requiring prospective validation due to the retrospective design and limited validation.
- 1 April 2026
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 13, 1-17
Open AccessContrast-Enhanced CT Shell Features and Deep Learning for Predicting Early Transarterial Chemoembolization Refractoriness in Hepatocellular Carcinoma
Purpose: The aim of this study was to develop and validate a predictive model for early refractoriness to transarterial chemoembolization (TACE)—termed early TACE refractoriness (ETR)—in patients with hepatocellular carcinoma (HCC). The model integrates contrast-enhanced CT (CECT) shell features (annular features at the tumor-liver parenchyma interface) with the Vision-Mamba (Vim) architecture, known for its efficiency in handling high-resolution medical images. Patients and Methods: This study was a two-center and retrospective study. Patients from center 1 were divided into the training set (n=254) and validation set (n=108), while patients from center 2 were used as the testing set (n=75). A joint model was constructed to predict ETR, and four Vim models without clinical features and 14 machine learning models based on clinical features were also developed for comparison. Model performance was evaluated by the accuracy, area under the curve (AUC), calibration curve, sensitivity, specificity, decision curve analysis (DCA) and Delong test. SHapley Additive exPlanations(SHAP) analysis were used to explain the predictions. Results: The combined model based on the Vim framework performs better than others. The AUC of the combined model in the training set, validation set and test set were 0.959, 0.956 and 0.942, respectively. The calibration curve and DCA verified the practicality of the combined model in clinical practice. SHAP provides a visual interpretation of the model. Conclusion: The Vim-based model integrating CECT and shell features shows promise for ETR prediction, offering a preliminary stratification tool. However, it remains a promising step rather than a definitive solution, requiring prospective validation due to the retrospective design and limited validation.
- 10 February 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 450, 134232
Comprehensive assesment of right ventricular function in patients with primary mitral regurgitation
- 10 February 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 450, 134232
Comprehensive assesment of right ventricular function in patients with primary mitral regurgitation
- 29 January 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (19) , e05516
Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection
Rejection following heart transplantation remains a significant challenge in the medical science. In addition to the immune response, the inflammatory response and microvascular endothelial damage can exacerbate rejection; however, current therapies focus primarily on the immune response. Numerous studies have confirmed that miR‐126 regulates vascular inflammation and promotes angiogenesis. To achieve the precise targeted delivery of miR‐126, macrophage biomimetic ultrasound phase‐change cationic nanoparticles carrying miR‐126 (miR‐126‐MCNPs) are synthesized. Incorporation of the macrophage membrane enhances the anti‐phagocytic and inflammatory targeting of nanoparticles, thereby prolonging the circulation time and promoting aggregation in the transplanted heart. Using ultrasound‐targeted microbubble destruction (UTMD), the perfluoropentane nanoparticle core undergoes a phase change in the ultrasound irradiation zone, allowing the targeted delivery of macrophage membranes and miR‐126, and significantly improving the transfection efficiency of the miR‐126. Consequently, anti‐inflammatory effects are achieved, such as inhibition of macrophage and CD3 + T cells infiltration, and alteration of M2‐type macrophage differentiation. In addition, this study demonstrates that the combination of miR‐126‐MCNPs with UTMD can alleviate the extent of vascular endothelial and interstitial fibrosis in transplanted hearts, increase angiogenesis, and improve microcirculation and cardiac function. This research provides a new strategy for the precision‐targeted therapy of cardiac transplant rejection.
- 29 January 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (19) , e05516
Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection
Rejection following heart transplantation remains a significant challenge in the medical science. In addition to the immune response, the inflammatory response and microvascular endothelial damage can exacerbate rejection; however, current therapies focus primarily on the immune response. Numerous studies have confirmed that miR‐126 regulates vascular inflammation and promotes angiogenesis. To achieve the precise targeted delivery of miR‐126, macrophage biomimetic ultrasound phase‐change cationic nanoparticles carrying miR‐126 (miR‐126‐MCNPs) are synthesized. Incorporation of the macrophage membrane enhances the anti‐phagocytic and inflammatory targeting of nanoparticles, thereby prolonging the circulation time and promoting aggregation in the transplanted heart. Using ultrasound‐targeted microbubble destruction (UTMD), the perfluoropentane nanoparticle core undergoes a phase change in the ultrasound irradiation zone, allowing the targeted delivery of macrophage membranes and miR‐126, and significantly improving the transfection efficiency of the miR‐126. Consequently, anti‐inflammatory effects are achieved, such as inhibition of macrophage and CD3 + T cells infiltration, and alteration of M2‐type macrophage differentiation. In addition, this study demonstrates that the combination of miR‐126‐MCNPs with UTMD can alleviate the extent of vascular endothelial and interstitial fibrosis in transplanted hearts, increase angiogenesis, and improve microcirculation and cardiac function. This research provides a new strategy for the precision‐targeted therapy of cardiac transplant rejection.
- Open Access
- 21 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (4) , 6639-6655
Macrophage-Mimicking Biomimetic Microbubbles for Early Ultrasound Molecular Imaging of Acute Rejection in Heart Transplantation
Acute rejection (AR) is an important cause of heart graft injury and failure. Accurate diagnosis of AR is essential to achieving early intervention and improving the prognosis of patients. Current clinical monitoring of AR requires repeated invasive endocardial biopsies, and there is an urgent need to develop a noninvasive diagnostic technique. As antigen-presenting cells, macrophages play an important role in adaptive immunity, such as the early activation of T cells in AR, and are considered to be key drivers of AR. Macrophage membrane biomimetic microbubbles (MB-Mφ) inherit a variety of functional proteins from the macrophage membranes. They can recognize and target the inflammatory site in the heart and use ultrasound imaging signals to determine the inflammatory progression of AR. This "ultrasound probe" can be regarded as a dynamic tracer and visualization tool for the behavior of macrophages. MB-Mφ prepared in this study showed superior stability and ultrasound imaging performance, and its ability to adhere to inflammatory vascular endothelial cells was significantly better than that of ordinary microbubbles (MB). In the rat allograft model, the signal intensity of the MB-Mφ group was significantly higher than that of the ordinary microbubbles group. In addition, after injection of MB-Mφ, the signal intensity in the allograft group was significantly higher than that in the isograft group, and the pathological results confirmed that the signal intensity of MB-Mφ was positively correlated with the number of macrophages infiltrating the transplanted heart and the progression of AR. These findings indicate that macrophage membrane biomimetic microbubbles can mimic the inflammatory chemotactic behavior of macrophages and noninvasively detect AR in heart transplantation, which provides a new molecular imaging tool for early diagnosis.
- 21 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (4) , 6639-6655
Open AccessMacrophage-Mimicking Biomimetic Microbubbles for Early Ultrasound Molecular Imaging of Acute Rejection in Heart Transplantation
Acute rejection (AR) is an important cause of heart graft injury and failure. Accurate diagnosis of AR is essential to achieving early intervention and improving the prognosis of patients. Current clinical monitoring of AR requires repeated invasive endocardial biopsies, and there is an urgent need to develop a noninvasive diagnostic technique. As antigen-presenting cells, macrophages play an important role in adaptive immunity, such as the early activation of T cells in AR, and are considered to be key drivers of AR. Macrophage membrane biomimetic microbubbles (MB-Mφ) inherit a variety of functional proteins from the macrophage membranes. They can recognize and target the inflammatory site in the heart and use ultrasound imaging signals to determine the inflammatory progression of AR. This "ultrasound probe" can be regarded as a dynamic tracer and visualization tool for the behavior of macrophages. MB-Mφ prepared in this study showed superior stability and ultrasound imaging performance, and its ability to adhere to inflammatory vascular endothelial cells was significantly better than that of ordinary microbubbles (MB). In the rat allograft model, the signal intensity of the MB-Mφ group was significantly higher than that of the ordinary microbubbles group. In addition, after injection of MB-Mφ, the signal intensity in the allograft group was significantly higher than that in the isograft group, and the pathological results confirmed that the signal intensity of MB-Mφ was positively correlated with the number of macrophages infiltrating the transplanted heart and the progression of AR. These findings indicate that macrophage membrane biomimetic microbubbles can mimic the inflammatory chemotactic behavior of macrophages and noninvasively detect AR in heart transplantation, which provides a new molecular imaging tool for early diagnosis.
- 5 December 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 706, 139626
Cell membrane-camouflaged chemotactic nanomotors for enhanced cancer chemotherapy
- 5 December 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 706, 139626
Cell membrane-camouflaged chemotactic nanomotors for enhanced cancer chemotherapy